Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase

Gang Cheng, Stephen P. Muench, Ying Zhou, Gustavo A. Afanador, Ernest J. Mui, Alina Fomovska, Bo Shiun Lai, Sean Taylor Prigge, Stuart Woods, Craig W. Roberts, Mark R. Hickman, Patty J. Lee, Susan E. Leed, Jennifer M. Auschwitz, David W. Rice, Rima McLeod

Research output: Contribution to journalArticle

Abstract

Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan's poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130.

Original languageEnglish (US)
Pages (from-to)2035-2043
Number of pages9
JournalBioorganic and Medicinal Chemistry Letters
Volume23
Issue number7
DOIs
StatePublished - Apr 1 2013

Fingerprint

Triclosan
Toxoplasma
Bioactivity
Ether
Oxidoreductases
Assays
Enzymes
Enzyme Assays
Therapeutic Uses
Solubility
Chemical properties
Permeability
Parasites
Derivatives

Keywords

  • ADMET
  • TgENR
  • Toxoplasma
  • Triclosan

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase. / Cheng, Gang; Muench, Stephen P.; Zhou, Ying; Afanador, Gustavo A.; Mui, Ernest J.; Fomovska, Alina; Lai, Bo Shiun; Prigge, Sean Taylor; Woods, Stuart; Roberts, Craig W.; Hickman, Mark R.; Lee, Patty J.; Leed, Susan E.; Auschwitz, Jennifer M.; Rice, David W.; McLeod, Rima.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 23, No. 7, 01.04.2013, p. 2035-2043.

Research output: Contribution to journalArticle

Cheng, G, Muench, SP, Zhou, Y, Afanador, GA, Mui, EJ, Fomovska, A, Lai, BS, Prigge, ST, Woods, S, Roberts, CW, Hickman, MR, Lee, PJ, Leed, SE, Auschwitz, JM, Rice, DW & McLeod, R 2013, 'Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase', Bioorganic and Medicinal Chemistry Letters, vol. 23, no. 7, pp. 2035-2043. https://doi.org/10.1016/j.bmcl.2013.02.019
Cheng, Gang ; Muench, Stephen P. ; Zhou, Ying ; Afanador, Gustavo A. ; Mui, Ernest J. ; Fomovska, Alina ; Lai, Bo Shiun ; Prigge, Sean Taylor ; Woods, Stuart ; Roberts, Craig W. ; Hickman, Mark R. ; Lee, Patty J. ; Leed, Susan E. ; Auschwitz, Jennifer M. ; Rice, David W. ; McLeod, Rima. / Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase. In: Bioorganic and Medicinal Chemistry Letters. 2013 ; Vol. 23, No. 7. pp. 2035-2043.
@article{9cc967f1a9c54f1db77c55aefd76c83d,
title = "Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase",
abstract = "Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan's poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130.",
keywords = "ADMET, TgENR, Toxoplasma, Triclosan",
author = "Gang Cheng and Muench, {Stephen P.} and Ying Zhou and Afanador, {Gustavo A.} and Mui, {Ernest J.} and Alina Fomovska and Lai, {Bo Shiun} and Prigge, {Sean Taylor} and Stuart Woods and Roberts, {Craig W.} and Hickman, {Mark R.} and Lee, {Patty J.} and Leed, {Susan E.} and Auschwitz, {Jennifer M.} and Rice, {David W.} and Rima McLeod",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.bmcl.2013.02.019",
language = "English (US)",
volume = "23",
pages = "2035--2043",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Design, synthesis, and biological activity of diaryl ether inhibitors of Toxoplasma gondii enoyl reductase

AU - Cheng, Gang

AU - Muench, Stephen P.

AU - Zhou, Ying

AU - Afanador, Gustavo A.

AU - Mui, Ernest J.

AU - Fomovska, Alina

AU - Lai, Bo Shiun

AU - Prigge, Sean Taylor

AU - Woods, Stuart

AU - Roberts, Craig W.

AU - Hickman, Mark R.

AU - Lee, Patty J.

AU - Leed, Susan E.

AU - Auschwitz, Jennifer M.

AU - Rice, David W.

AU - McLeod, Rima

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan's poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130.

AB - Triclosan is a potent inhibitor of Toxoplasma gondii enoyl reductase (TgENR), which is an essential enzyme for parasite survival. In view of triclosan's poor druggability, which limits its therapeutic use, a new set of B-ring modified analogs were designed to optimize its physico-chemical properties. These derivatives were synthesized and evaluated by in vitro assay and TgENR enzyme assay. Some analogs display improved solubility, permeability and a comparable MIC50 value to that of triclosan. Modeling of these inhibitors revealed the same overall binding mode with the enzyme as triclosan, but the B-ring modifications have additional interactions with the strongly conserved Asn130.

KW - ADMET

KW - TgENR

KW - Toxoplasma

KW - Triclosan

UR - http://www.scopus.com/inward/record.url?scp=84875231794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875231794&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2013.02.019

DO - 10.1016/j.bmcl.2013.02.019

M3 - Article

C2 - 23453069

AN - SCOPUS:84875231794

VL - 23

SP - 2035

EP - 2043

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 7

ER -